Polymer–drug conjugates for novel molecular targets

Author： Sanchis Joaquin   Canal Fabiana   Lucas Rut   Vicent María J  

Publisher： Future Medicine

ISSN： 1743-5889

Source： Nanomedicine, Vol.5, Iss.6, 2010-08, pp. : 915-935

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Vision for Drug Discovery and Development: Novel Targets and Multilateral Partnerships

By McIntyre Roger  

Advances in Therapy, Vol. 31, Iss. 3, 2014-03 ,pp. : 245-246

Springer Publishing Company

Access to resources Recommend Favorite

Class II Phosphoinositide 3-Kinases as Potential Novel Drug Targets

By  

Current Signal Transduction Therapy, Vol. 8, Iss. 2, 2013-08 ,pp. : 101-112

Bentham Science Publishers

Access to resources Recommend Favorite

Insight into the molecular pathophysiology of myelodysplastic syndromes: targets for novel therapy

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 97, Iss. 4, 2016-10 ,pp. : 313-320

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetics of coronary heart disease: towards causal mechanisms, novel drug targets and more personalized prevention

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 278, Iss. 5, 2015-11 ,pp. : 433-446

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lipid-Drug Conjugates for Oral Bioavailability Enhancement

By  

Recent Patents on Nanomedicine, Vol. 5, Iss. 2, 2015-01 ,pp. : 87-95

Bentham Science Publishers

Access to resources Recommend Favorite